RECRO PHARMA INC shareholders Q3 2023

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

RECRO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
HOURGLASS CAPITAL, LLC 60,000$28,1400.01%
Alyeska Investment Group, L.P. 1,597,931$749,4300.01%
Weaver Consulting Group 20,199$9,4730.00%
KORNITZER CAPITAL MANAGEMENT INC /KS 350,000$164,1500.00%
Amplius Wealth Advisors, LLC 47,800$22,4180.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 249,600$117,0620.00%
WYNNEFIELD CAPITAL INC 13,000$6,0970.00%
STEPHENS INC /AR/ 313,198$146,8900.00%
First Eagle Investment Management, LLC 1,631,431$765,1410.00%
Renaissance Technologies 836,017$3920.00%
External links

This page lists RECRO PHARMA INC's shareholders in Q3 2023. To view RECRO PHARMA INC's shareholder history, click here.